Clinical Trial Update: Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update shows completion of a study evaluating functional outcomes in postpartum depression treated with desvenlafaxine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: BC Women's Hospital & Health Centre | Conditions: Depression | Phase 3 | Status: COMPLETED